Clinical Trial Update: An Open-Label Treatment Protocol to Provide Continued Elvucitabine Treatment [Phase 2]

View source ↗

Summary

Open-label Phase 2 trial update describing continued elvucitabine treatment for HIV infections after completion of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Elvucitabine (elvucitabine)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: HIV Infections | Phase 2 | Status: COMPLETED